KCNMA1
Calcium-activated potassium channel subunit alpha-1
Also known as: KCa1.1, KCMA1_HUMAN, mSLO1, SLO
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q12791
- Gene
- KCNMA1
- Ensembl
- ENSG00000156113
- Chromosome
- 10
- Canonical length
- 1236 aa
- Protein class
- Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This gene encodes the alpha subunit of calcium-activated BK channel. The encoded protein is involved in several physiological processes including smooth muscle contraction, neurotransmitter release and neuronal excitability. Mutations in this gene are associated with a spectrum of neurological disorders including Paroxysmal Nonkinesigenic Dyskinesia 3, Idiopathic Generalized Epilepsy 16 and Liang-Wang syndrome. [provided by RefSeq, Aug 2022]
Canonical amino-acid sequenceUniProt
1236 residues, UniProt reviewed canonical sequence.
>Q12791|KCNMA1
1 MANGGGGGGG SSGGGGGGGG SSLRMSSNIH ANHLSLDASS SSSSSSSSSS SSSSSSSSSS
61 VHEPKMDALI IPVTMEVPCD SRGQRMWWAF LASSMVTFFG GLFIILLWRT LKYLWTVCCH
121 CGGKTKEAQK INNGSSQADG TLKPVDEKEE AVAAEVGWMT SVKDWAGVMI SAQTLTGRVL
181 VVLVFALSIG ALVIYFIDSS NPIESCQNFY KDFTLQIDMA FNVFFLLYFG LRFIAANDKL
241 WFWLEVNSVV DFFTVPPVFV SVYLNRSWLG LRFLRALRLI QFSEILQFLN ILKTSNSIKL
301 VNLLSIFIST WLTAAGFIHL VENSGDPWEN FQNNQALTYW ECVYLLMVTM STVGYGDVYA
361 KTTLGRLFMV FFILGGLAMF ASYVPEIIEL IGNRKKYGGS YSAVSGRKHI VVCGHITLES
421 VSNFLKDFLH KDRDDVNVEI VFLHNISPNL ELEALFKRHF TQVEFYQGSV LNPHDLARVK
481 IESADACLIL ANKYCADPDA EDASNIMRVI SIKNYHPKIR IITQMLQYHN KAHLLNIPSW
541 NWKEGDDAIC LAELKLGFIA QSCLAQGLST MLANLFSMRS FIKIEEDTWQ KYYLEGVSNE
601 MYTEYLSSAF VGLSFPTVCE LCFVKLKLLM IAIEYKSANR ESRILINPGN HLKIQEGTLG
661 FFIASDAKEV KRAFFYCKAC HDDITDPKRI KKCGCKRPKM SIYKRMRRAC CFDCGRSERD
721 CSCMSGRVRG NVDTLERAFP LSSVSVNDCS TSFRAFEDEQ PSTLSPKKKQ RNGGMRNSPN
781 TSPKLMRHDP LLIPGNDQID NMDSNVKKYD STGMFHWCAP KEIEKVILTR SEAAMTVLSG
841 HVVVCIFGDV SSALIGLRNL VMPLRASNFH YHELKHIVFV GSIEYLKREW ETLHNFPKVS
901 ILPGTPLSRA DLRAVNINLC DMCVILSANQ NNIDDTSLQD KECILASLNI KSMQFDDSIG
961 VLQANSQGFT PPGMDRSSPD NSPVHGMLRQ PSITTGVNIP IITELVNDTN VQFLDQDDDD
1021 DPDTELYLTQ PFACGTAFAV SVLDSLMSAT YFNDNILTLI RTLVTGGATP ELEALIAEEN
1081 ALRGGYSTPQ TLANRDRCRV AQLALLDGPF ADLGDGGCYG DLFCKALKTY NMLCFGIYRL
1141 RDAHLSTPSQ CTKRYVITNP PYEFELVPTD LIFCLMQFDH NAGQSRASLS HSSHSSQSSS
1201 KKSSSVHSIP STANRQNRPK SRESRDKQKY VQEERLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KCNMA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 121 nTPM
Expression across tissuesHPA
Tissue
- endometrium: 121 nTPM
- colon: 112 nTPM
- smooth muscle: 94 nTPM
- skeletal muscle: 92 nTPM
- blood vessel: 90 nTPM
- cervix: 77 nTPM
Single-cell type
- retinal bipolar cells: 1,790 nCPM
- salivary ionocytes: 1,695 nCPM
- salivary acinar cells: 1,517 nCPM
- ependymal cells: 1,321 nCPM
- myonuclei: 1,080 nCPM
- lacrimal acinar cells: 1,058 nCPM
Immune cell
- intermediate monocyte: 2.5 nTPM
- non-classical monocyte: 1.7 nTPM
- memory B-cell: 0.7 nTPM
- myeloid DC: 0.3 nTPM
- classical monocyte: 0.1 nTPM
- naive B-cell: 0.1 nTPM
Brain region
- cerebral cortex: 160 nTPM
- amygdala: 142 nTPM
- basal ganglia: 130 nTPM
- hippocampal formation: 127 nTPM
- white matter: 124 nTPM
- thalamus: 101 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KCNMA1.
Disease | AllUniProt
Conditions KCNMA1 is implicated in, by any mechanism.
- Paroxysmal non-kinesigenic dyskinesia 3 with or without generalized epilepsy (PNKD3) MIM:609446
- Epilepsy, idiopathic generalized 16 (EIG16) MIM:618596
- Cerebellar atrophy, developmental delay, and seizures (CADEDS) MIM:617643
- Liang-Wang syndrome (LIWAS) MIM:618729
Disease | GeneticClinVar
48 pathogenic / likely-pathogenic of 1,540 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Generalized epilepsy-paroxysmal dyskinesia syndrome
- Liang-Wang syndrome
- Cerebellar atrophy, developmental delay, and seizures
- KCNMA1-related disorder
- Inborn genetic diseases
Disease | ImmuneIEDB
Conditions an epitope on KCNMA1 was assayed in.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.28
- gnomAD pLI
- 1
- gnomAD missense Z
- 5.06
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- intracellular potassium ion homeostasis
- micturition
- negative regulation of cell volume
- positive regulation of apoptotic process
- potassium ion transmembrane transport
- potassium ion transport
- regulation of membrane potential
- response to calcium ion
- response to carbon monoxide
- response to hypoxia
- response to osmotic stress
- smooth muscle contraction involved in micturition
- vasodilation
Molecular functions
- actin binding
- calcium-activated potassium channel activity
- identical protein binding
- metal ion binding
- voltage-gated potassium channel activity
- large conductance calcium-activated potassium channel activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Regulator of K+ conductance, N-terminal lobe
- Calcium-activated potassium channel BK, alpha subunit
- Ion transport domain
- NAD(P)-binding domain superfamily
- Calcium-activated potassium channel slowpoke-like
- Ca2+-activated K+ channel Slowpoke-like, C-terminal domain
- Ion transport protein
- Calcium-activated BK potassium channel alpha subunit
- Ca2+-activated K+ channel Slowpoke, TrkA_C like domain
- Calcium-activated potassium channel slowpoke-like RCK domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KCNMA1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KCNMA1 as an antibody target. Whether an autoantibody or antibody against KCNMA1 could matter depends on whether native KCNMA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KCNMA1 is annotated at the cell surface, where native KCNMA1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KCNMA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...